Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion type Assertion NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_head.
- NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion description "[Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_provenance.
- NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion evidence source_evidence_literature NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_provenance.
- NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion SIO_000772 10985480 NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_provenance.
- NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion wasDerivedFrom befree-20140225 NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_provenance.
- NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_assertion wasGeneratedBy ECO_0000203 NP422173.RAQodX7SETM3e_m-SmeoB4OsfxAe_hQNTVbcDYRXaVSUU130_provenance.